Clinical Outcomes in Metabolically Healthy and Unhealthy Obese and Overweight Patients With Atrial Fibrillation: Findings From the GLORIA-AF Registry

被引:10
|
作者
Corica, Bernadette [1 ,2 ,3 ]
Romiti, Giulio Francesco [1 ,2 ,3 ]
Proietti, Marco [1 ,2 ,4 ,5 ]
Mei, Davide Antonio [1 ,2 ,6 ]
Boriani, Giuseppe [6 ]
Chao, Tze-Fan [7 ,8 ,9 ]
Olshansky, Brian [10 ]
V. Huisman, Menno [11 ]
Lip, Gregory Y. H. [12 ,13 ]
机构
[1] Univ Liverpool, Liverpool John Moores Univ, Liverpool Ctr Cardiovasc Sci, Liverpool, England
[2] Liverpool Heart & Chest Hosp, Liverpool, England
[3] Sapienza Univ Rome, Dept Translat & Precis Med, Rome, Italy
[4] Univ Milan, Dept Clin Sci & Community Hlth, Milan, Italy
[5] IRCCS Ist Clin Sci Maugeri, Geriatr Unit, Milan, Italy
[6] Univ Modena & Reggio Emilia, Cardiol Div, Dept Biomed Metab & Neural Sci, Policlin Modena, Modena, Italy
[7] Taipei Vet Gen Hosp, Dept Med, Div Cardiol, Taipei, Taiwan
[8] Natl Yang Ming Chiao Tung Univ, Inst Clin Med, Taipei, Taiwan
[9] Natl Yang Ming Chiao Tung Univ, Cardiovasc Res Ctr, Taipei, Taiwan
[10] Univ Iowa Hosp & Clin, Dept Internal Med, Div Cardiol, Iowa City, IA USA
[11] Leiden Univ, Med Ctr, Dept Thrombosis & Hemostasis, Leiden, Netherlands
[12] Aalborg Univ, Danish Ctr Hlth Serv Res, Dept Clin Med, Aalborg, Denmark
[13] Univ Liverpool, Liverpool Ctr Cardiovasc Sci, William Henry Duncan Bldg,6 W Derby St, Liverpool L7 8TX, England
关键词
BODY-MASS INDEX; WEIGHT; MANAGEMENT; RISK; ASSOCIATION; PREVENTION; REDUCTION; MORTALITY; PARADOX; DISEASE;
D O I
10.1016/j.mayocp.2023.07.013
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To explore the association between metabolic status, body mass index (BMI), and natural history of patients with atrial fibrillation (AF). Methods: The global, prospective GLORIA-AF Registry Phase II and III included patients with recent diagnosis of AF between November 2011 and December 2014 for Phase II and between January 2014 and December 2016 for Phase III. With this analysis, we categorized patients with AF according to BMI (normal weight [18.5 to 24.9 kg/m2], overweight [25.0 to 29.9 kg/m2], obese [30.0 to 60.0 kg/m2]) and metabolic status (presence of hypertension, diabetes, and hyperlipidemia). We analyzed risk of major outcomes using multivariable Cox regression analyses; the primary outcome was the composite of all-cause death and major adverse cardiovascular events. Results: There were 24,828 (mean age, 70.1 +/- 10.3 years; 44.6% female) patients with AF included. Higher BMI was associated with metabolically unhealthy status and higher odds of receiving oral anticoagulants and other treatments. Normal-weight unhealthy patients showed a higher risk of the primary composite outcome (adjusted hazard ratio [aHR], 1.20; 95% CI, 1.01 to 1.42) and thromboembolism, whereas a lower risk of cardiovascular death (aHR, 0.35; 95% CI, 0.14 to 0.88) and major adverse cardiovascular events (aHR, 0.56; 95% CI, 0.33 to 0.93) was observed in metabolically healthy obese individuals. Unhealthy metabolic groups were also associated with increased risk of major bleeding (aHR, 1.51 [95% CI, 1.04 to 2.20] and aHR, 1.96 [95% CI, 1.34 to 2.85] in overweight and Conclusion: Increasing BMI was associated with poor metabolic status and with more intensive treatment. Prognosis was heterogeneous between BMI groups, with metabolically unhealthy patients showing higher risk of adverse events. (c) 2023 THE AUTHORS. Published by Elsevier Inc on behalf of Mayo Foundation for Medical Education and Research. This is an open access article under
引用
收藏
页码:927 / 939
页数:13
相关论文
共 50 条
  • [21] Atrial fibrillation and comorbidities: Clinical characteristics and antithrombotic treatment in GLORIA-AF
    Koziel, Monika
    Teutsch, Christine
    Halperin, Jonathan L.
    Rothman, Kenneth J.
    Diener, Hans-Christoph
    Ma, Chang-Sheng
    Marler, Sabrina
    Lu, Shihai
    Gurusamy, Venkatesh K.
    Huisman, Menno, V
    Lip, Gregory Y. H.
    PLOS ONE, 2021, 16 (04):
  • [22] Patterns of pharmacological treatment in patients with atrial fibrillation: an analysis from the prospective GLORIA-AF Registry Phase III
    Corica, Bernadette
    Romiti, Giulio Francesco
    Boriani, Giuseppe
    Olshansky, Brian
    Chao, Tze-Fan
    Huisman, Menno V.
    Proietti, Marco
    Lip, Gregory Y. H.
    GLORIA AF Investigators
    BMC MEDICINE, 2025, 23 (01):
  • [23] Use of antithrombotic therapy in patients with atrial fibrillation and prior stroke: insights from the global GLORIA-AF registry
    Lip, G. Y. H.
    Halperin, J. L.
    Diener, H. C.
    Dubner, S. J.
    Ma, C. S.
    Rothman, K. J.
    Zint, K.
    Elsaesser, A.
    Paquette, M.
    Huisman, M. V.
    EUROPEAN HEART JOURNAL, 2015, 36 : 243 - 243
  • [24] Stroke-prevention strategies in North American patients with atrial fibrillation: The GLORIA-AF registry program
    McIntyre, William F.
    Conen, David
    Olshansky, Brian
    Halperin, Jonathan L.
    Hayek, Emil
    Huisman, Menno V.
    Lip, Gregory Y. H.
    Lu, Shihai
    Healey, Jeff S.
    CLINICAL CARDIOLOGY, 2018, 41 (06) : 744 - 751
  • [25] Patterns of oral anticoagulant use and outcomes in Asian patients with atrial fibrillation: a post-hoc analysis from the GLORIA-AF Registry
    Romiti, Giulio Francesco
    Corica, Bernadette
    Proietti, Marco
    Mei, Davide Antonio
    Frydenlund, Juliane
    Bisson, Arnaud
    Boriani, Giuseppe
    Olshansky, Brian
    Chan, Yi-Hsin
    V. Huisman, Menno
    Chao, Tze-Fan
    Lip, Gregory Y. H.
    ECLINICALMEDICINE, 2023, 63
  • [26] Residual Risks of Thrombotic Complications in Anticoagulated Patients with Atrial Fibrillation: A Cluster Analysis Approach from the GLORIA-AF Registry
    Ishiguchi, Hironori
    Abdul-Rahim, Azmil H.
    Huang, Bi
    Lam, Steven Ho Man
    Liu, Yang
    Olshansky, Brian
    Chao, Tze-Fan
    Huisman, Menno V.
    Lip, Gregory Y. H.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2024,
  • [27] SAFETY AND EFFECTIVENESS OF DABIGATRAN IN PATIENTS WITH ATRIAL FIBRILLATION WITH AND WITHOUT PRIOR STROKE: DATA FROM THE GLORIA-AF REGISTRY PROGRAM
    Diener, H. C.
    Teutsch, C.
    Huisman, M. V.
    Dubner, S. J.
    Ma, C. S.
    Rothman, K. J.
    Lu, S.
    Paquette, M.
    Zint, K.
    Franca, L. R.
    Halperin, J. L.
    Lip, G. Y. H.
    INTERNATIONAL JOURNAL OF STROKE, 2018, 13 : 99 - 99
  • [28] Regional Differences in Antithrombotic Treatment for Atrial Fibrillation: Insights from the GLORIA-AF Phase II Registry
    Mazurek, Michal
    Huisman, Menno V.
    Rothman, Kenneth J.
    Paquette, Miney
    Teutsch, Christine
    Diener, Hans-Christoph
    Dubner, Sergio J.
    Halperin, Jonathan L.
    Ma, Chang Sheng
    Zint, Kristina
    Elsaesser, Amelie
    Lu, Shihai
    Lip, Gregory Y. H.
    THROMBOSIS AND HAEMOSTASIS, 2017, 117 (12) : 2376 - 2388
  • [29] Characteristics of Patients With Asymptomatic Atrial Fibrillation and Ischemic Stroke-Insights From the GLORIA-AF Registry (Phase 2)
    Heer, Tobias
    Zeymer, Uwe
    Schwarzbach, Christopher J.
    Seidl, Karlheinz
    Rauch-Kroehnert, Ursula
    Marler, Sabrina
    Teutsch, Christine
    Diener, Hans-Christoph
    Senges, Jochen
    Lip, Gregory Y. H.
    Huisman, Menno V.
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2025, 48 (01): : 42 - 49
  • [30] Adherence to the Atrial Fibrillation Better Care (ABC) pathway and the risk of major outcomes in patients with atrial fibrillation: A post-hoc analysis from the prospective GLORIA-AF Registry
    Romiti, Giulio Francesco
    Proietti, Marco
    Bonini, Niccolo
    Ding, Wern Yew
    Boriani, Giuseppe
    Huisman, Menno, V
    Lip, Gregory Y. H.
    ECLINICALMEDICINE, 2023, 55